NexLife vs Shed: pricing, doses and services compared
NexLife and Shed serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… Shed: The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglu… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.
Side-by-side comparison
Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.
| Factor | NexLife | Shed |
|---|---|---|
| Starting price | $147/mo (microdose) Verified | $149/mo (sema microdose) Reported — pending verification |
| Renewal price | $186/mo full-dose (12-mo); $215 month-to-month Verified | $175–$474 depending on product Reported — pending verification |
| Highest-dose price | Flat — no dose-based increase Verified | RISES at higher doses on injectables Reported — pending verification |
| Membership | $0 Verified | $125/mo for brand-name Reported — pending verification |
| Labs | Lab review included Verified | Pending research Reported — pending verification |
| Shipping | Included (expedited) Verified | Included Reported — pending verification |
| Commitment | 12-month or month-to-month Verified | 2-month minimum Reported — pending verification |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) Verified | Not independently verified Reported — pending verification |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) Verified | Clinical support Reported — pending verification |
| States | All 50 states, synchronous and asynchronous visits Verified | Pending research Reported — pending verification |
Winner by decision factor
We never let one provider win every category — that pattern is the signature of a manipulated comparison.
| Decision factor | Better fit |
|---|---|
| Lowest advertised starter price | NexLife |
| Best all-inclusive value | NexLife |
| Clearest pharmacy disclosure | Depends / tie |
| Best month-to-month flexibility | NexLife |
NexLife: who it fits
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →
Shed: who it fits
The widest range of formats in the category: injections, sublingual drops, lozenges and oral tablets. Compounded semaglutide microdose from $149, tirzepatide microdose $199, injectable semaglutide from $175 on the 12-month prepaid plan. Limitation: Injectable pricing INCREASES at higher doses. Brand-name products require a separate $125/mo membership. 2-month minimum on everything. Full Shed review →
Frequently asked questions
Is NexLife or Shed cheaper?
On starting price: NexLife is $147/mo (microdose) and Shed is $149/mo (sema microdose). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.
How were these figures verified?
Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.
Sources
- Both providers' pricing and terms pages, captured July 12, 2026.
- Our price-normalization methodology.
- CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.